Tag Archives: Partnering

Harder, Better, Faster, Stronger: Takeaways from Partnering For Cures 2012

Drug Manufacturing

The chorus to Kanye West’s 2007 chart-topper Stronger can teach us volumes about speeding drug development. Harder:  Drug development is challenging.  It takes over 10 years and more than $1 billon to bring a therapy through the product pipeline, from the research lab to clinical trials to FDA approval to prescription to patients suffering from the disease. The FDA approved over 30 innovative drugs last year, including more than 10 new treatments for cancer—a good Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Some ABCs of PAGs

Blocks

A lot of people, and especially those who have attended BIO events (such as the BIO CEO & Investor Conference, BIO Investor Forum, and the BIO Business Forum) are familiar with the names Michael J. Fox Foundation, FasterCures, ALS Therapy Development Institute, JDRF, and other non-profit Patient Advocacy Groups, or “PAG’s”. In case you missed them, two blog posts came up from the Michael J. Fox Foundation and FasterCures that we wanted to share. They Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

What BIO2012 Meant to Boston and the Netherlands

The 2012 BIO International Convention will be held June 18-21, 2012 at the Boston Convention and Exhibition Center in Boston, MA

We came across this recent post in Boston.com about the BIO International Convention and BIO Business Forum. It’s not just a recap of the event, but it’s a specific piece on one company’s goals, connecting Boston with the Netherlands. As you know, the BIO One-on-One Partnering System is open and accessible to attendees well after the conference shuts down and everyone goes home. This allows you to do your follow-up: go through your Inbox, research Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , ,

2012 BIO Investor Forum: Looking Ahead to Investment Opportunities

partnering1

The biggest biotech news out of Washington in recent months was the Jumpstart Our Business Startups (JOBS) Act, which passed Congress overwhelmingly and was signed into law by President Obama in April.  For those not familiar, the JOBS Act creates a new category of issuers, called “emerging growth companies” (EGCs), which is defined as newly public companies with than $1 billion in annual revenues and a public float below $700 million. EGCs are given a Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

Recommended Reading from BIOtechNOW

Partnering Meetings

We hope the dust has settled from Boston’s International Convention, and you’re ready for a busy fall schedule! Here’s just a quick post on some recent articles that have been published on BIOtechNOW that’s worth a read. 2012 Fall Event Preview – A recap of BIO’s upcoming BD events, among others. 2012 BIO Convention in China: Highlighting Cross-Border Partnering in Biotechnology – Take a deeper look at the 2nd Annual BIO China event. We’re also Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,